Quantcast

LEGAL NEWSLINE

Thursday, March 28, 2024

Arkansas man files class action against opioid manufacturers over unjust enrichment allegations

Medical malpractice 01

FAYETTEVILLE, Ark. (Legal Newsline) – A consumer has filed a suit against several manufacturers and/or sellers of prescription opioids over allegations of misrepresentations about the drugs.

Michael Ray Lewis filed a complaint on behalf of himself and all others similarly situated on June 29 in the U.S. District Court for the Western District of Arkansas, Fayetteville Division against Purdue Pharma LP, Purdue Pharma Inc.; Teva Pharmaceuticals USA Inc., Cephalon Inc. and Johnson & Johnson, et al. alleging unjust enrichment and other counts.

According to the complaint, the plaintiff alleges that he was prescribed opioids in 2005 and has had numerous prescriptions filled over the years. The suit states he has been treated for addiction related to his opioid prescriptions.

The plaintiff holds Purdue Pharma LP, Purdue Pharma Inc.; Teva Pharmaceuticals USA Inc., Cephalon Inc. and Johnson & Johnson, et al. responsible because the defendants allegedly made materially misleading misrepresentations regarding the addictive nature of opioids and were enriched at the expense of the plaintiff and the proposed class.

The plaintiff requests a trial by jury and seeks damages, restitution, disgorgement, monetary relief, interest, all legal fees and any other relief as the court deems just. He is represented by Thomas P. Thrash and Marcus Neil Bozeman of Thrash Law Firm PC in Little Rock, Arkansas and by Kenneth R. Shemin of Shemin Law Firm in Rogers, Arkansas.

U.S. District Court for the Western District of Arkansas case number 5:17-cv-05118-TLB

More News